Similar Search Results

Jones, Andrew M. (contributor) - 2006

The aim of The Elgar Companion to Health Economics is to take an audience of advanced undergraduates, postgraduates and researchers to the frontier of research in health economics, by providing them with short and easily readable introductions to key topics. The volume brings together 50...

Persistent link: https://www.econbiz.de/10011851278

The dictionary of health economics

Culyer, Anthony J. - 2005

From Abscissa, through to the World Health Organization, this expansive Dictionary comprehensively covers the field of health economics and closely related fields including epidemiology, pharmacoeconomics, demography, medical sociology, medical statistics and bio-statistics, health policy,...

Persistent link: https://www.econbiz.de/10014474138

Cost-benefit analysis and health care evaluations

Brent, Robert J. - 2003

Cost-benefit analysis is the only method of economic evaluation which can effectively indicate whether a health care treatment or intervention is worthwhile. This book attempts to build a bridge between cost-benefit analysis, as developed by economists, and the health care evaluation literature...

Persistent link: https://www.econbiz.de/10012420110

The economics of health care in Asia-Pacific countries

Hu, Teh-wei (ed.); Hsieh, Chee-Ruey (ed.) - 2002

In order to control ever-increasing health care expenditure, Western and Asian countries are seeking to develop more efficient health care models. Studies on health care that focus specifically on Asian countries are rare, rendering this a unique and welcome addition to the literature. This book...

Persistent link: https://www.econbiz.de/10014474098

The dictionary of health economics

Culyer, Anthony J. - 2010 - 2nd ed

This second edition of Culyer's authoritative Dictionary of Health Economics brings the material up to date and adds large amounts of new information. Some definitions have been revised. There are over 700 new entries. The Dictionary now also contains extensive references to the literature to...

Persistent link: https://www.econbiz.de/10012420094

The economics of health behaviours

Kenkel, Donald Scott (contributor); … - 2008

', Journal of Econometrics, 93, 49-72 -- Jonathan Gruber and Botond Köszegi (2001), 'Is Addiction "Rational"? Theory and Evidence …Recommended readings (Machine generated): H. Leibenstein (1950), 'Bandwagon, Snob, and Veblen Effects in the Theory of … Kevin M. Murphy (1988), 'A Theory of Rational Addiction', Journal of Political Economy, 96 (4), August, 675-700 -- Engelbert …

Persistent link: https://www.econbiz.de/10011852231

Corporate governance, the firm and investor capitalism : legal-political and economic views

Styhre, Alexander - 2016

-agent relations, and free market advocacy -- Part II: rethinking the firm -- 3. The agency theory model of the firm and its …: neoclassical economic theory and ideology. … economic boom, and after 1980 in the era of free market advocacy. Covering the theory of the firm from the New Deal era until …

Persistent link: https://www.econbiz.de/10012419829

Cyberfactories : how news agencies produce news

Czarniawska-Joerges, Barbara - 2011

Have you ever wondered how organizations decide which news is important? This insightful book portrays in detail everyday work in three news agencies: Swedish TT, Italian ANSA and the worldwide Reuters. This unique study is about organizing rather than journalism, revealing two accelerating...

Persistent link: https://www.econbiz.de/10011851557

The public financing of pharmaceuticals : an economic approach

Puig-Junoy, Jaume (contributor) - 2005

This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and...

Persistent link: https://www.econbiz.de/10011851613

Pharmaceutical economics

Comanor, William S. - 2013

Pharmaceutical Economics begins with an investigation of the structure of the industry and its three main components: the research firms which produce innovative products; the generic drug industry and its expanding role; and the biotech industry, which is regarded as the future for...

Persistent link: https://www.econbiz.de/10011852149

1
2
3
4
5
6
7
8
9
10
Next
Last